MOLOGEN Competitors and Similar CompaniesClear all
MOLOGEN's competitors and similar companies include Advaxis and Immunocore.
 MOLOGEN MOLOGEN AG is a biotechnology company specializing in the research and clinical development of innovative drugs in the fields of oncology and infectious diseases. |  Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 2002 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Berlin, DE HQ | Locations Princeton, US HQ | Locations Milton, GB HQ Conshohocken, US Rockville, US |
Employees | Employees 4710% decrease | Employees 3540% decrease | Employees 493 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 m | Valuation ($) 1.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) €81k (FY, 2019) | Revenue (est.) $13k (FY, 2023) | Revenue (est.) $400m (FY, 2025) |
Cost of goods | Cost of goods €2m (FY, 2019) | Cost of goods $13k (FY, 2023) | Cost of goods $5.1m (FY, 2025) |
Gross profit | Gross profit (€1.5m) (FY, 2019) | Gross profit N/A | Gross profit $414.7m (FY, 2025) |
Net income | Net income (€10.3m) (FY, 2019) | Net income ($48.1m) (FY, 2023) | Net income ($35.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 50.5m | Total funding raised $ 565m |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View companyImmunocore
HQ
Milton, GB
Employees
493
Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases.
View company